| 期 |
栏目 |
标题 |
文件 |
| 卷 6, 编号 2 (2009) |
Articles |
Efficacy of metoprolol in treatment and preventive of cardiovascular diseases |
|
| 卷 9, 编号 4 (2012) |
Articles |
Stress-induced arterial hypertension – clinical features and treatment options |
|
| 卷 9, 编号 4 (2012) |
Articles |
Iloprost for acute tests in patients with pulmonary arterial hypertension |
|
| 卷 10, 编号 2 (2013) |
Articles |
Use of diuretics in hypertensive patients with metabolic disturbances |
|
| 卷 10, 编号 2 (2013) |
Articles |
Legochnaya arterial'naya gipertenziya: na puti ot ratsional'noy diagnostiki k vyboru effektivnoy lekarstvennoy terapii |
|
| 卷 10, 编号 3 (2013) |
Articles |
Primenenie diuretikov u bol'nykh arterial'noy gipertoniey s metabolicheskimi narusheniyami |
|
| 卷 10, 编号 2 (2013) |
Articles |
Do spirometry for patients with cardiovascular diseases? |
|
| 卷 10, 编号 4 (2013) |
Articles |
The prevalence of arterial hypertension as a risk factor of cardiovascular diseases in one of the cities in Siberian Federal District |
|
| 卷 10, 编号 3 (2013) |
Articles |
Izuchenie kognitivnykh funktsiy mozga u bol'nykh arterial'noy gipertoniey s nalichiem ili otsutstviem metabolicheskogo sindroma |
|
| 卷 10, 编号 4 (2013) |
Articles |
Coagulogic risk factors of heart disease in the adult population of Tomsk |
|
| 卷 10, 编号 3 (2013) |
Articles |
Sindrom obstruktivnogo apnoe sna i disfunktsiya endoteliya |
|
| 卷 10, 编号 4 (2013) |
Articles |
The effects of climate in patients with arterial hypertension, including in combination with chronic obstructive pulmonary disease and/or bronchial asthma |
|
| 卷 10, 编号 4 (2013) |
Articles |
Riociguatas the first innovative guanylatecyclase stimulators class drugs for pulmonary arterial hypertension patients treatment |
|
| 卷 11, 编号 1 (2014) |
Articles |
Hypertension treatment features in perimenopausal women |
(Rus)
|
| 卷 11, 编号 1 (2014) |
Articles |
Risk of target organ damage in patients with arterial hypertension and various numbers of metabolic syndrome components |
(Rus)
|
| 卷 11, 编号 2 (2014) |
Articles |
Efficacy and safety of amlodipine and perindopril (Prestance) fixed combination in patients with arterial hypertension during the summer heat |
(Rus)
|
| 卷 11, 编号 2 (2014) |
Articles |
Recommendations on treatment strategies in hypertensivepatientswithmetabolic disorders |
(Rus)
|
| 卷 11, 编号 3 (2014) |
Articles |
The results of the open observational, international, multicenter, prospective program to assess the efficacy, safety and tolerability of the first direct renin inhibitor RasilezR (aliskiren) in patients with arterial hypertension in ‘real-life’ clinical practice settings (DRIve) |
(Rus)
|
| 卷 11, 编号 3 (2014) |
Articles |
Education and self-education of the patients is an important step towards increasing patients acceptance of therapy |
(Rus)
|
| 卷 11, 编号 4 (2014) |
Articles |
Methods of sympathetic activity evaluation in patients with systemic refractory hypertension |
(Rus)
|
| 卷 11, 编号 4 (2014) |
Articles |
Role of the Pulse Oximetry in the cardiologist's practice |
(Rus)
|
| 卷 11, 编号 4 (2014) |
Articles |
The prevalence of carotid atherosclerosis in spontaneous populations in Tomsk |
(Rus)
|
| 卷 11, 编号 4 (2014) |
Articles |
The state of the vascular wall in adult population of Tomsk in the framework of the project ESSAY RF |
(Rus)
|
| 卷 12, 编号 2 (2015) |
Articles |
Cardioncology: management of arterial hypertension in patients with cancer on chemotherapy |
(Rus)
|
| 卷 11, 编号 4 (2014) |
Articles |
The treatment options of the new angiotensin II receptor blocker - azilsartan medoxomil in the therapy of hypertension in patients with metabolic disorders |
(Rus)
|
| 卷 11, 编号 4 (2014) |
Articles |
The development of a screening questionnaire to improve the early detection of pulmonary arterial hypertension |
(Rus)
|
| 卷 12, 编号 2 (2015) |
Articles |
Efficacy and safety of different regimens of fixed combinationof perindopril 10 mg/indapamide 2.5 mg in patients with arterial hypertension |
(Rus)
|
| 卷 12, 编号 2 (2015) |
Articles |
Calcium channel blockers: more than 50 years on guard of health |
(Rus)
|
| 卷 12, 编号 2 (2015) |
Articles |
Possibilities of electrocardiographic and decartographic parametersin the diagnosis of right ventricular overload in patients with pulmonary arterial hypertension |
(Rus)
|
| 卷 12, 编号 2 (2015) |
Articles |
Clinical case: combination therapy with iloprost and sildenafil in the treatment of idiopathic pulmonary hypertension |
(Rus)
|
| 卷 12, 编号 2 (2015) |
Articles |
The first results of an international clinical trial VICTORY:the efficacy and safety of antihypertensive valsartan monotherapy and the fixed combination of valsartan and hydrochlorothiazide usingdifferent dosage regimens in patients with 1-2 degree arterial hypertension |
(Rus)
|
| 卷 12, 编号 1 (2015) |
Articles |
Radiofrequency renal arteries denervation: waiting for reply |
(Rus)
|
| 卷 12, 编号 1 (2015) |
Articles |
The role of beta-blockers in the treatment of arterial hypertension: what do we know today |
(Rus)
|
| 卷 12, 编号 3 (2015) |
Articles |
Experts of RMSAH opinion: the fixed combination of azilsartan medoxomil and chlortalidone is broadening options of the combined therapyin patients with arterial hypertension |
(Rus)
|
| 卷 12, 编号 1 (2015) |
Articles |
Effects of amlodipine and atorvastatin on endothelial vasoactive mediators in patients with metabolic syndrome |
(Rus)
|
| 卷 12, 编号 3 (2015) |
Articles |
The prevalence of renal dysfunction in arterial hypertension (in the framework of the ESSE-RF study) |
(Rus)
|
| 卷 12, 编号 1 (2015) |
Articles |
Patients with arterial hypertension associated with metabolic disorders: characteristics and therapeutic approach |
(Rus)
|
| 卷 12, 编号 1 (2015) |
Articles |
Safety of beta-agonists with different duration of action in patients with arterial hypertension and broncho-obstructive diseases |
(Rus)
|
| 卷 12, 编号 3 (2015) |
Articles |
Radiofrequency denervation of renal arteries. Myth or reality? |
(Rus)
|
| 卷 12, 编号 3 (2015) |
Articles |
The first Russian experience of sildenafil application in patients with idiopathic pulmonary hypertension |
(Rus)
|
| 卷 12, 编号 4 (2015) |
Articles |
Myocardial ischemia in patients with pulmonary arterial hypertension |
(Rus)
|
| 卷 12, 编号 4 (2015) |
Articles |
Comparison of vectorcardiographic parameters with structural-functional state of the right ventricle in patients with pulmonary hypertension |
(Rus)
|
| 卷 13, 编号 1 (2016) |
Articles |
The validation of the questionnaire for the early detection of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension |
(Rus)
|
| 卷 14, 编号 4 (2017) |
Articles |
Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Parts II-V |
(Rus)
|
| 卷 14, 编号 3 (2017) |
Articles |
Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Part I |
(Rus)
|
| 卷 14, 编号 3 (2017) |
Articles |
Markers of early cardiotoxicity in patients with breast cancer undergoing chemotherapy depending on blood pressure level |
(Rus)
|
| 卷 14, 编号 3 (2017) |
Articles |
The new angiotensin II receptor blocker Edarbi® as part of the pathogenetic treatment of arterial hypertension in patients with metabolic disorders |
(Rus)
|
| 卷 15, 编号 1 (2018) |
Articles |
Clinical manual for diagnosis, prevention and treatment of cardiovascular complications of cancer therapy. Parts VI-VII |
(Rus)
|
| 卷 15, 编号 1 (2018) |
Articles |
The place of intervention methods of treatment of patients with resistant hypertension in clinical practice |
(Rus)
|
| 卷 15, 编号 1 (2018) |
Articles |
The problem of broncho-obstructive syndrome early detection in cardiological patients. Review of specialized respiratory questionnaires and their use in patients with comorbid cardiovascular and broncho-obstructive pathologies |
(Rus)
|
| 卷 15, 编号 2 (2018) |
Articles |
The influence of antyhypertensive therapy of valsartan and fixed combination with hydrochlorothiazide use on pulse-wave velocity and central arterial pressure in patients with arterial hypertension of 1-2 grades in international VICTORY clinical trial |
(Rus)
|
| 卷 15, 编号 1 (2018) |
Articles |
The prevalence of diabetes mellitus in population of hypertensive patients according to ESSE RF study results |
(Rus)
|
| 卷 15, 编号 2 (2018) |
Articles |
State of the art for diagnosis and treatment of orthostatic hypotension |
(Rus)
|
| 卷 15, 编号 3 (2018) |
Articles |
Guidelines for diagnostics and treatment of hypertension 2018 - European experts’opinion [Guidelines] |
(Rus)
|
| 卷 15, 编号 3 (2018) |
Articles |
Resistant and refractory arterial hypertension: similarities and differences, new approaches to diagnosis and treatment |
(Rus)
|
| 卷 15, 编号 2 (2018) |
Articles |
Continuous positive airway pressure (CPAP) therapy in patients with obstructive sleep apnea syndrome and arterial hypertension: expert opinion |
(Rus)
|
| 卷 15, 编号 3 (2018) |
Articles |
Obesity as a predictor for cardiovascular disease development: role of localized fat depot |
(Rus)
|
| 卷 15, 编号 4 (2018) |
Articles |
Polypill" conception in modern cardiology |
(Rus)
|
| 卷 15, 编号 4 (2018) |
Articles |
Radiofrequency renal denervation with different device for treatment in patient with uncontrolled hypertension |
(Rus)
|
| 卷 15, 编号 4 (2018) |
Articles |
Evaluation of subclinical cardiotoxicity in patients with breast cancer and arterial hypertension in two regimens of anthracycline-containing chemotherapy |
(Rus)
|
| 卷 15, 编号 4 (2018) |
Articles |
Epicardial fat: a new cardiometabolic risk marker, a new therapeutic goal in obese patients |
(Rus)
|
| 卷 15, 编号 4 (2018) |
Articles |
Communication of subcutaneous, visceral, periaortic, epicardial fat and metabolic parameters with arterial stiffness in young people with abdominal obesity |
(Rus)
|
| 卷 6, 编号 1 (2009) |
Articles |
The place of b-blocker and diuretic in the Russian guidelines of arterial hypertension 2008 |
|
| 卷 6, 编号 3 (2009) |
Articles |
Whether all ACE inhibitors enzyme are identical? Focus on zofenopril. |
|
| 卷 6, 编号 1 (2009) |
Articles |
Obstructive sleep apnea syndrome |
|
| 卷 6, 编号 1 (2009) |
Articles |
Final results of STRATEGYA Study (Russian Comparative Programme on a fixed,low-dose perindopril/indapamide combination efficacy in hypertensive patients with inadequateblood pressure control): use of a fixed, low- dose perindopril/indapamide combination in hypertensivepatients in real clinical practice |
|
| 卷 6, 编号 3 (2009) |
Articles |
Mesto agonistov imidazolinovykh retseptorov v lechenii arterial'noy gipertenzii: rezul'taty issledovaniya MERSY v Rossii |
|
| 卷 6, 编号 1 (2009) |
Articles |
Metabolic syndrome |
|
| 卷 6, 编号 4 (2009) |
Articles |
Diuretics in treatment of patients with arterial hypertension |
|
| 卷 6, 编号 1 (2009) |
Articles |
Possible combinations of antihypertensive drugs at treatment of arterial hypertension at patientswith metabolic syndrome |
|
| 卷 6, 编号 1 (2009) |
Articles |
Clinical case: Effectiveness of combined therapyOrlistat and Irbesartan at the Metabolic syndrome patient with Arterial hypertension |
|
| 卷 6, 编号 4 (2009) |
Articles |
Three calcium antagonists: a place of everyone in treatment arterial hypertension (ALTERNATIVE study) |
|
| 卷 6, 编号 1 (2009) |
Articles |
Renovaskulyarnaya arterial'naya gipertenziya: diagnostika i lechenie |
|
| 卷 6, 编号 4 (2009) |
Articles |
Fleita is a Russian randomized, open-label, multicenter, comparative program for the evaluation of the efficacy and safety of the fixed combination drug Tarka (ABBOTT Laboratories, USA) versus optional sustained-release antihypertensive drugs in the treatment of patients with arterial hypertension and cognitive disorders (stepwise strategy) |
|
| 卷 6, 编号 4 (2009) |
Articles |
The improved form perindopril in treatment of arterial hypertension in various clinical situations (PREMIA) |
|
| 卷 6, 编号 4 (2009) |
Articles |
Direct renin inhibitors aliskiren - possibilities correction cardiorenal syndrome |
|
| 卷 16, 编号 2 (2019) |
Articles |
Dynamics of ECG indicators in patients with chronic thromboembolic pulmonary hypertension after transluminal pulmonary balloon angioplasty |
(Rus)
|
| 卷 16, 编号 4 (2019) |
Articles |
Consensus on patients with hyperuricemia and high cardiovascular risk treatment |
(Rus)
|
| 卷 16, 编号 4 (2019) |
Articles |
Long-term outcomes after percutaneous transluminal pulmonary angioplasty for chronic thromboembolic pulmonary hypertension |
(Rus)
|
| 卷 16, 编号 3 (2019) |
Articles |
The possibilities of angiotensin receptor blocker azilsartan medoxomil and its combination with chlortalidone in cardiovascular risk decrease in patients with obesity, metabolic syndrome and diabetes mellitus |
(Rus)
|
| 卷 16, 编号 4 (2019) |
Articles |
Uncontrolled arterial hypertension in patients with breast cancer and the risk of developing cardiotoxicity with anthracycline-containing chemotherapy |
(Rus)
|
| 卷 16, 编号 2 (2019) |
Articles |
Possibilities of blood pressure and metabolic disorders correction by using diet programs in patients with overweight and obesity |
(Rus)
|
| 卷 16, 编号 3 (2019) |
Articles |
Gender characteristics of obstructive sleep apnea syndrome clinical manifestations and patients' quality of life |
(Rus)
|
| 卷 16, 编号 4 (2019) |
Articles |
Vascular wall status and its link with perivascular adipose tissue and other fat depots in young patients with abdominal obesity |
(Rus)
|
| 卷 17, 编号 1 (2020) |
Original Article |
Radiofrequency renal denervation with mono-electrode and multi-electrode device for treatment in patient with uncontrolled hypertension: results of a 6-month follow-up |
(Rus)
|
| 卷 17, 编号 4 (2020) |
Articles |
Gender-age peculiarities of smoking and diabetes mellitus role in the development of myocardial infarction in patients with arterial hypertension |
(Rus)
|
| 卷 17, 编号 2 (2020) |
Original Article |
First results of Russian multicenter prospective clinical study VICTORY II: Vamloset® and Co-Vamloset effectiveness and safety in patients with stage 2 and 3 arterial hypertension |
(Rus)
|
| 卷 17, 编号 2 (2020) |
Original Article |
The effect of adherence with long-term PAP therapy on the psycho-emotional state of patients with obstructive sleep apnea syndrome |
(Rus)
|
| 卷 17, 编号 2 (2020) |
Review |
Pulmonary hypertension or cardiology aerobatics |
(Rus)
|
| 卷 17, 编号 2 (2020) |
Review |
COVID-19: a patient with cardiovascular disease at high risk |
(Rus)
|
| 卷 17, 编号 3 (2020) |
Original Article |
Speckle-tracking echocardiography in 3D mode in assessing the deformation of the myocardium and identifying subclinical cardiotoxicity during chemotherapy in breast cancer patients with arterial hypertension |
(Rus)
|
| 卷 17, 编号 3 (2020) |
Original Article |
Parameters of acute vasoreactivity testing after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension |
(Rus)
|
| 卷 17, 编号 3 (2020) |
Expert opinion |
Russian Medical Society for Arterial Hypertension Expert Consensus: Hypertension and COVID-19 |
(Rus)
|
| 卷 17, 编号 4 (2020) |
Articles |
Russian medical society on arterial hypertension (RMSAH) Consensus of Experts on the use of radiofrequency denervation of the renal arteries in patients with arterial hypertension |
(Rus)
|
| 卷 17, 编号 3 (2020) |
Guidelines |
Clinical practice guidelines on the diagnosis and treatment of patients with arterial hypertension and chronic obstructive pulmonary disease |
(Rus)
|
| 卷 17, 编号 4 (2020) |
Articles |
PAP-therapy adherence in patients with obstructive sleep apnea and cardiovascular diseases |
(Rus)
|
| 卷 17, 编号 4 (2020) |
Articles |
Impact of metabolic syndrome parameters and different fat depots on arterial stiffness in patients with abdominal obesity |
(Rus)
|
| 卷 17, 编号 4 (2020) |
Articles |
Efficacy and safety of using a fixed-dose combination of azilsartan medoxomil and chlorthalidone in patients with diabetes mellitus |
(Rus)
|
| 卷 17, 编号 4 (2020) |
Articles |
Assessment of epicardial adipose tissue by echocardiography for risk stratification in young adults with abdominal obesity |
(Rus)
|
| 卷 18, 编号 1 (2021) |
Review |
Uncontrolled arterial hypertension: main causes, features of pathogenesis and approaches to treatment |
(Rus)
|
| 卷 18, 编号 1 (2021) |
Expert opinion |
Expert consensus. Effect of antihypertensive therapy on cognitive functions |
(Rus)
|
| 卷 18, 编号 1 (2021) |
Original Article |
Aspects of efficacy, safety and adherence to antihypertensive therapy with single pill combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with 2 and 3 grade of arterial hypertension in the Russian clinical study VICTORY II |
(Rus)
|
| 卷 18, 编号 2 (2021) |
Expert opinion |
Consensus of experts from the Russian Medical Society of Arterial Hypertension. Arterial hypertension and erectile dysfunction |
(Rus)
|
| 卷 18, 编号 3 (2021) |
Original Article |
Clinical features and course of arterial hypertension in patients with its various forms |
(Rus)
|
| 卷 18, 编号 3 (2021) |
Expert opinion |
Management of patients with arterial hypertension and atrial fibrillation |
(Rus)
|
| 卷 18, 编号 3 (2021) |
Original Article |
Efficacy and safety of azilsartan medoxomil in various doses in patients with metabolic disorders |
(Rus)
|
